Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the ...

By Jonathan Stempel NEW YORK, Feb 23 (Reuters) - Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely ...

Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...

Bayer filed a lawsuit against Johnson & Johnson and its Janssen Biotech unit, alleging that marketing claims regarding the superiority of J&J's Erleada prostate-cancer drug versus Bayer's Nubeqa are ...

Bayer has filed a false advertising lawsuit taking issue with claims made by Johnson & Johnson to pit their prostate cancer drugs against one another. | Bayer has filed a false advertising lawsuit ...

Patients treated with Xofigo-Xtandi experienced a 5.6-month boost to median OS over those treated with Xtandi alone.

Philadelphia jury orders Johnson & Johnson to pay damages in a talc related ovarian cancer case, the first plaintiff win there since litigation restarted. Verdict comes after prior bankruptcy efforts ...

The Bayer Pharma AG logo is seen on April 03, 2025 in Berlin, Germany. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...

Werner Baumann, CEO of Leverkusen, Germany-based Bayer, on Wednesday shared his thoughts on rising drug costs, his company’s own drug pricing system and President Donald Trump in an interview with ...

Bayer sued Johnson and Johnson, alleging false advertising for its prostate cancer drug Erleada, claiming it misleads patients.

Suit alleges that J&J made "false claims regarding the efficacy of Nubeqa," Bayer's drug that former NFL quarterback Tony ...